Table 1. Demographic characteristics of the study population with and without HP therapy.
| Characteristics | Group A Patients with HP therapy (≤ 365 days) (n = 3164) | Group B Patients without HP therapy (n = 3164) | P value | ||
|---|---|---|---|---|---|
| N | % | N | % | ||
| HP therapy* | |||||
| First | 3141 | 99.27% | -- | -- | |
| HP4+HP3+HP1 | 3081 | 98.09% | -- | -- | |
| HP4+HP3+HP2 | 2 | 0.06% | -- | -- | |
| HP5+HP3+HP1 | 101 | 3.22% | -- | -- | |
| HP5+HP3+HP2 | 1 | 0.03% | -- | -- | |
| Second | 24 | 0.76% | -- | -- | |
| HP4+HP6+HP8+HP2 | 0 | 0.00% | -- | -- | |
| HP5+HP6+HP8+HP2 | 0 | 0.00% | -- | -- | |
| HP4+HP7+HP1 | 19 | 79.17% | -- | -- | |
| HP5+HP7+HP1 | 9 | 37.50% | -- | -- | |
| Age, years old (mean ± SD) | 47.73±14.24 | 47.73±14.24 | 1.0000 | ||
| Age_Class1 | |||||
| < 49 | 1821 | 57.55% | 1821 | 57.55% | 0.9951 |
| 50–59 | 713 | 22.53% | 713 | 22.53% | |
| 60–69 | 353 | 11.16% | 354 | 11.19% | |
| ≥ 70 | 277 | 8.75% | 276 | 8.72% | |
| Age_Class2 | |||||
| < 65 | 2741 | 86.63% | 2741 | 86.63% | 1.0000 |
| ≥ 65 | 423 | 13.37% | 423 | 13.37% | |
| Gender | |||||
| Male | 1895 | 59.89% | 1896 | 59.92% | 0.9795 |
| Female | 1269 | 40.11% | 1268 | 40.08% | |
| Charlson score | |||||
| 0 | 2441 | 77.15% | 2441 | 77.15% | 0.9998 |
| 1 | 649 | 20.51% | 648 | 20.48% | |
| 2 | 69 | 2.18% | 70 | 2.21% | |
| ≥ 3 | 5 | 0.16% | 5 | 0.16% | |
| Charlson score (mean ± SD) | 0.25±0.49 | 0.25±0.49 | 1.0000 | ||
| Charlson comorbidity | |||||
| Dementia | 5 | 0.16% | 5 | 0.16% | 1.0000 |
| Pulmonary disease | 95 | 3.00% | 95 | 3.00% | 1.0000 |
| Connective tissue disorder | 14 | 0.44% | 14 | 0.44% | 1.0000 |
| Peptic ulcer | 535 | 16.91% | 535 | 16.91% | 1.0000 |
| Liver disease | 131 | 4.14% | 130 | 4.11% | 1.0000 |
| Paraplegia | 0 | 0.00% | 1 | 0.03% | 0.3173 |
| Renal disease | 11 | 0.35% | 11 | 0.35% | 1.0000 |
| Comorbidity | |||||
| Hypertension | 286 | 9.04% | 287 | 9.07% | 0.9651 |
| Hyperlipidemia | 115 | 3.63% | 115 | 3.63% | 1.0000 |
Abbreviations: HP, Helicobacter pylori; HIV, human immunodificiency virus
*HP1 = Amoxicillin, HP2 = Metronidazole, HP3 = Clarithromycin, HP4 = PPI, HP5 = H2 blockers, HP6 = Bismuth, HP7 = Levofloxacin, HP8 = Tetracycline